Cargando…

Development of mutome-specific personalized vaccines for pancreatic cancer

Detalles Bibliográficos
Autores principales:	Lutz, Eric, Kinkead, Heather, Yager, Allison, Armstrong, Todd, Lauer, Peter, Brockstedt, Dirk, Dubensky, Thomas, Jaffee, Elizabeth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3990984/ http://dx.doi.org/10.1186/2051-1426-1-S1-P224

Ejemplares similares

Clinical experience with live-attenuated, double-deleted (LADD) listeria monocytogenes targeting mesothelin-expressing tumors
por: Brockstedt, Dirk G, et al.
Publicado: (2013)

A Phase IIb, randomized, multicenter study of the efficacy of GVAX pancreas vaccine and CRS-207 compared to chemotherapy or to CRS-207 alone in adults with previously-treated metastatic pancreatic adenocarcinoma (eclipse study)
por: Wang-Gillam, Andrea, et al.
Publicado: (2014)

Phase I study of safety and immunogenicity of ADU-623, a live-attenuated listeria monocytogenes vaccine (ΔactA/ΔinlB) expressing EGFRVIII and NY-ESO-1, in patients with who grade III/IV astrocytomas
por: Crittenden, Marka, et al.
Publicado: (2015)

Integrative analysis of a cancer somatic mutome
por: Hernández, Pilar, et al.
Publicado: (2007)

Modified STING-activating cyclic dinucleotide derivatives significantly enhance the anti-tumor activity of therapeutic vaccines
por: Leong, Meredith, et al.
Publicado: (2013)

Randomized Phase II study of the safety, efficacy and immune response of GVAX pancreas (with cyclophosphamide) and CRS-207 with or without nivolumab in patients with previously treated metastatic pancreatic adenocarcinoma (STELLAR)
por: Le, Dung T, et al.
Publicado: (2015)

Long term survivors and immune biomarker analysis of Phase IIa, randomized study of GVAX pancreas and crs-207 immunotherapy in patients with metastatic pancreatic cancer
por: Nair, Nitya, et al.
Publicado: (2015)

Direct activation of STING in the tumor microenvironment partially overcomes immune tolerance in neu-N transgenic mice
por: Foote, Jeremy, et al.
Publicado: (2015)

Dipeptidyl peptidase 3 and thimet oligopeptidase 1 knockdown support tumor-specific immune responses to whole cell cancer vaccines and tumor cell death in vivo
por: Gamrekelashvili, Jaba, et al.
Publicado: (2013)

Role of in silico structural modeling in predicting immunogenic neoepitopes for cancer vaccine development
por: Zaidi, Neeha, et al.
Publicado: (2020)

Anti-pancreatic tumor efficacy of a Listeria-based, Annexin A2-targeting immunotherapy in combination with anti-PD-1 antibodies
por: Kim, Victoria M., et al.
Publicado: (2019)

Anti-mesothelin vaccine CRS-207 with or without low-dose cyclophosphamide plus chemotherapy as front-line treatment for malignant pleural mesothelioma (MPM)
por: Hassan, Raffit, et al.
Publicado: (2015)

Serotonergic modulation of respiratory neural activity during tadpole development
por: Gulemetova, R, et al.
Publicado: (2001)

Concomitant effect of dopamine and acetylcholine on carotid body chemosensory response to hypoxia in the cat
por: Bairam, A, et al.
Publicado: (2001)

Neonatal maternal separation alters development of the hypercapnic ventilatory response in awake adult rats
por: Genest, SE, et al.
Publicado: (2001)

Cyclic dinucleotides (CDNs) reversed T cells tolerance in anti-tumor immunotherapy
por: Fu, Juan, et al.
Publicado: (2015)

A Potent and Effective Suicidal Listeria Vaccine Platform
por: Hanson, William G., et al.
Publicado: (2019)

Radiation therapy and vaccination against tumor-specific EGFRvIII effectively clears tumors in a murine model of head and neck squamous cell carcinoma
por: Uhde, Lauren, et al.
Publicado: (2015)

Mesothelin-specific CD8(+) T Cell Responses Provide Evidence of In Vivo Cross-Priming by Antigen-Presenting Cells in Vaccinated Pancreatic Cancer Patients
por: Thomas, Amy Morck, et al.
Publicado: (2004)

Intratumoral injection of STING ligand promotes abscopal effect
por: Baird, Jason R, et al.
Publicado: (2014)

Find the match! A tool for residue-specific analysis of epitopes in Bet v 1-like allergens
por: Schiller, Dirk, et al.
Publicado: (2014)

Motivators to participation in HIV vaccine trials and cancer trials: the application of personal and social categorization
por: Dhalla, S, et al.
Publicado: (2012)

Preclinical testing of a novel personalized cancer vaccine for all solid tumors and all patients
por: Jackson, Doreen, et al.
Publicado: (2015)

Vaccine therapy for pancreatic cancer
por: Salman, Bulent, et al.
Publicado: (2013)

Interleukin-21 activates natural killer cell activity against cetuximab-coated pancreatic tumor cells
por: McMichael, Elizabeth L, et al.
Publicado: (2015)

Vaccine-specific T-cell proliferation in response to a dual peptide cancer vaccine in breast and ovarian cancer patients
por: Schneble, Erika J, et al.
Publicado: (2013)

Association of haptoglobin genetic polymorphism with overall survival in advanced castration-resistant prostate cancer patients with personalized peptide vaccination
por: Komatsu, Nobukazu, et al.
Publicado: (2013)

The utility of procalcitonin for the patients with infected pancreatic necrotic and pancreatic abscess
por: Adachi, T, et al.
Publicado: (2015)

Personalized immunotherapy for non-small cell lung cancer through identification of tumor-specific mutations by next generation sequencing and adoptive transfer of tumor infiltrating lymphocytes that recognize neoantigens
por: Hanada, Ken-ichi, et al.
Publicado: (2015)

Whole body irradiation and agonist anti-CD40 synergize to promote adoptive T cell therapy of resistant murine pancreatic neuroendocrine tumors
por: Ward-Kavanagh, Lindsay, et al.
Publicado: (2015)

Antigen-specific TIL therapy for melanoma: a flexible platform for personalized cancer immunotherapy
por: Kelderman, Sander, et al.
Publicado: (2013)

Suppression of Cell-Mediated Immunity following Recognition of Phagosome-Confined Bacteria
por: Bahjat, Keith S., et al.
Publicado: (2009)

Metabolic biomarkers for the differential diagnosis of pancreatic ductal adenocarcinoma vs. chronic pancreatitis
por: Mayerle, Julia, et al.
Publicado: (2014)

Personalized evidence of treatment effects for the practice of personalized medicine: a new model of care
por: Collet, Jean-Paul, et al.
Publicado: (2014)

Severe acute pancreatitis in the ICU
por: Poddar, B, et al.
Publicado: (2006)

Case autoimmune pancreatitis in children
por: Cazares Camacho, Alicia G, et al.
Publicado: (2014)

Severity markers in acute pancreatitis
por: Jalkanen, S
Publicado: (2015)

A291 CLINICAL OUTCOMES IN PATIENTS WITH MODERATE TO SEVERE PANCREATITIS AND PANCREATIC COLLECTIONS: A RETROSPECTIVE COHORT STUDY
por: Kundra, A, et al.
Publicado: (2023)

Efficacy of vaccine-induced Vif-specific CTL responses against SIVmac239 infection: implications for antigen design in AIDS vaccines
por: Iwamoto, N, et al.
Publicado: (2012)

Mortality predictors in acute pancreatitis admitted to the ICU
por: Vidal-Cortés, P, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_bihevca716c56cvup8bj5j2vrq